Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis.
Radiologically isolated syndrome: An update on a rare entity.
Longitudinally extensive transverse myelitis: A retrospective analysis of sixty-four patients at tertiary care center of North-West India.
Mast cells: New therapeutic target in helminth immune modulation.
Treatment for Krabbe's disease: Finding the combination.
Dimethyl fumarate may still have a role in progressive multiple sclerosis.
Optic Neuritis in a Patient with Bickerstaff's Brainstem Encephalitis.
Differences in iron and manganese concentration may confound the measurement of myelin from R1 and R2 relaxation rates in studies of dysmyelination.
Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair.
The future of multiple sclerosis treatments.
Ontogeny of Tissue-Resident Macrophages.
Intravenous Immunoglobulins Lower Inflammatory Gene Expression in Skin Biopsies of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
Fatigue and gait speed in multiple sclerosis: Assessment and relationship.
Peripheral neuropathy in patients with myotonic dystrophy type 2.
Comparative evaluation of patients' and physicians' satisfaction with interferon beta-1b therapy.
From trash to treasure: The untapped potential of endothelial microparticles in neurovascular diseases.
Deciphering the role of DNA methylation in multiple sclerosis: emerging issues.
Modeling the Chronic Loss of Optic Nerve Axons and the Effects on the Retinal Nerve Fiber Layer Structure in Primary Disorder of Myelin.
Simulations on the influence of myelin water in diffusion-weighted imaging.
Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder.
[Monoclonal antibodies, overview and outlook of a promising therapeutic option].
The Transition to Secondary Progressive Multiple Sclerosis: An Exploratory Qualitative Study of Health Professionals' Experiences.
Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
Comment on Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography.
Pages
« first
‹ previous
…
771
772
773
774
775
776
777
778
779
…
next ›
last »